triterpen
saponin
repres
one
common
class
plant
natur
product
broad
spectra
biolog
pharmacolog
activ
glycyrrhiz
acid
ga
bioactiv
saponin
root
glycyrrhiza
glabra
l
g
uralensi
fisher
leguminosa
known
antiinflammatori
antiulc
antiallerg
antidot
antitumor
immunotrop
activ
ga
one
lead
natur
glycosid
promis
scaffold
design
new
nontox
antivir
agent
ga
inhibit
influenza
viru
epsteinbarr
herp
hepat
b
c
sarsassoci
coronaviru
etc
ga
possess
new
mechan
antivir
activ
exhibit
activ
earli
stage
viru
replic
cycl
stimul
product
structur
similar
ga
conjug
system
triterpen
part
respons
similar
biolog
activ
prolong
administr
high
dose
ga
salt
induc
mineralocorticoid
activ
affect
watersalt
exchang
enhanc
na
retent
lower
vivo
k
content
pseudoaldosteron
therefor
synthesi
ga
analog
reduc
group
interest
structureact
relationship
studi
propos
earlier
method
reduc
ga
nabh
thf
heat
h
reflux
h
result
acid
ii
isol
pentaoacet
iii
obtain
rule
glycosid
acet
insolubl
aqueou
solut
unsuit
studi
antivir
activ
cell
cultur
ga
analog
reduc
group
synthes
earlier
ii
vi
accord
literatur
ga
reduc
etoh
h
ga
nabh
ratio
eq
reflux
h
afford
deriv
v
first
isol
reaction
mixtur
treat
hcl
dioxan
produc
mixtur
ga
analog
ii
dienoic
acid
vi
separ
column
chromatographi
cc
silica
gel
sg
trimethyl
ester
iv
vii
scheme
glycosid
vi
contain
heteroannular
dien
system
triterpen
part
natur
minor
saponin
root
g
uralensi
licoricesaponin
c
glycosid
observ
inhibit
cytopathogen
activ
cell
concentr
mmol
glycosid
ii
contain
homoannular
dien
system
aglycon
semisynthet
ga
analog
antivir
properti
report
reduct
ga
nabh
etoh
h
carri
reflux
h
order
prepar
standard
sampl
ii
simpler
method
result
glycosid
v
dehydr
without
preliminari
isol
use
aqueou
hcl
instead
hcl
solut
aqueou
dioxan
mixtur
acidifi
ph
room
temperatur
stir
h
product
extract
nbuoh
afford
crude
product
mixtur
glycosid
contain
ga
analog
homodien
ii
accord
hplc
tabl
mixtur
addit
purifi
salt
use
strong
cationexchang
h
form
etoh
result
sampl
separ
cc
sg
gradient
elut
chcl
meoh
h
see
experiment
glycosid
ii
isol
pure
yield
character
ir
nmr
spectra
also
convert
known
trimethyl
ester
iv
ir
spectrum
ii
miss
absorpt
maximum
pmr
spectrum
contain
two
singlet
olefin
proton
chemic
shift
cs
ppm
cod
c
nmr
spectrum
character
new
reson
olefin
c
atom
weak
field
ppm
agre
literatur
ga
reduc
excess
nabh
reflux
h
order
increas
yield
ii
work
reaction
mixtur
hcl
ph
subsequ
extract
buoh
describ
gave
crude
product
overal
yield
crude
glycosid
dissolv
etoh
work
cation
exchang
h
form
order
remov
salt
glycosid
separ
use
cc
sg
elut
chcl
meoh
h
tlc
monitor
fraction
tabl
present
result
tabl
show
content
desir
product
obtain
sampl
accord
hplc
reduct
ga
excess
nabh
eq
reflux
h
h
yield
pure
ii
separ
cc
loss
chromatographi
remain
fraction
contain
insepar
glycosid
mixtur
cytotox
activ
ii
studi
use
tradit
model
primari
hivinfect
strain
lymphoid
cell
describ
compar
ga
cytotox
ii
assay
graft
human
tlymphocyt
line
cultur
use
dmso
solut
appropri
dilut
incub
incub
finish
fraction
vital
cell
count
goryaev
chamber
stain
trypan
blue
dosedepend
curv
construct
drug
concentr
caus
death
cell
cd
cytotox
dose
determin
activ
ii
assay
cell
cultur
cellsml
infect
inhibit
effect
assay
use
immunoenzym
method
cultur
measur
amount
viru
antigen
virusspecif
protein
cultur
liquid
dosedepend
curv
construct
use
result
quantit
inhibit
characterist
calcul
ic
concentr
compound
suppress
viru
product
protect
cell
death
due
infect
ic
concentr
compound
suppress
viru
product
protect
cell
death
due
infect
si
select
index
ie
ratio
cc
effect
concentr
ic
tabl
present
result
glycosid
ii
practic
nontox
time
less
toxic
cell
ga
furthermor
ii
exhibit
pronounc
activ
inhibit
accumul
virusspecif
protein
si
time
ga
effect
ii
rnadepend
dnapolymeras
activ
recombin
revers
transcriptas
rt
studi
without
variou
concentr
drug
use
rt
studi
show
ii
inhibit
highli
effect
rnadepend
dnapolymeras
activ
rt
effect
concentr
ii
inhibit
rt
ic
mgml
thu
high
activ
inhibit
rt
cell
cultur
found
ii
first
time
pmr
c
nmr
spectra
record
bruker
spectromet
germani
oper
frequenc
h
c
mhz
chemic
shift
report
rel
tm
intern
standard
reson
assign
use
highresolut
nmr
data
ga
ir
spectra
miner
oil
mull
record
shimadzu
spectromet
uv
spectra
meoh
solut
record
spectrophotomet
germani
element
analysi
perform
euro
ea
analyz
determin
error
theoret
hplc
carri
shimadzu
ad
liquid
chromatograph
use
silasorb
column
mm
mobil
phase
mecn
h
hoac
vol
diod
detector
nm
mobil
phase
flow
rate
mlmin
inject
sampl
volum
ml
mgml
determin
error
tlc
use
kieselgel
f
merck
tlc
sorbfil
sorbopolim
ukrain
plate
aluminum
back
spot
detect
h
solut
etoh
subsequ
heat
min
cc
use
ksk
fraction
sorbopolim
sigmaaldrich
fraction
silica
gel
use
nabh
pancreac
quimica
u
ga
prepar
commerci
monoammonium
salt
accord
literatur
pure
standard
hplc
activ
studi
purifi
ga
prepar
sampl
ii
prepar
publish
method
solut
ga
g
mmol
etoh
h
ml
treat
nabh
mmol
heat
h
reflux
h
cool
room
temperatur
acidifi
hcl
ph
stir
h
treat
h
ml
extract
buoh
ml
buoh
extract
wash
h
ml
dri
mgso
evapor
dryness
residu
dissolv
etoh
ml
work
cation
exchang
h
form
cation
exchang
filter
wash
etoh
filtrat
evapor
result
sampl
analyz
hplc
separ
synthesi
activ
evapor
dryness
residu
dissolv
etoh
ml
work
cation
exchang
h
form
cation
exchang
filter
wash
etoh
filtrat
evapor
result
sampl
analyz
hplc
separ
cc
sg
describ
yield
pure
ii
b
solut
ga
g
mmol
h
ml
treat
portion
nabh
mmol
heat
min
complet
dissolv
reflux
h
cool
room
temperatur
acidifi
hcl
ph
stir
h
treat
h
ml
extract
buoh
ml
buoh
extract
wash
h
ml
dri
mgso
evapor
dryness
residu
dissolv
etoh
ml
work
cation
exchang
h
form
product
analyz
hplc
separ
cc
describ
tabl
cytotox
activ
ii
cell
cultur
cytotox
compound
assay
cell
cultur
describ
drug
dissolv
dmso
appli
appropri
dilut
plate
well
three
well
dilut
seed
cell
cellsml
final
drug
concentr
cell
suspens
mgml
mgml
cell
cultiv
cultur
plate
costar
usa
growth
medium
ad
fetal
calf
serum
lglutamin
gentamicin
mgml
atmospher
co
incub
finish
fraction
vital
cell
count
goryaev
chamber
stain
trypan
blue
dosedepend
curv
construct
cytotox
drug
concentr
caus
death
cell
cc
determin
antivir
activ
ii
studi
tradit
method
primari
infect
hiv
graft
human
tlymphocyt
cell
line
use
strain
cell
cellsml
infect
strain
infect
unit
per
cell
order
assay
activ
ii
viru
adsorb
h
infect
control
cell
without
viru
dilut
growth
medium
cellsml
place
cultur
plate
appropri
well
treat
solut
ii
dmso
three
well
dilut
cultiv
describ
final
drug
concentr
cell
suspens
refer
drug
ga
concentr
mgml
inhibit
effect
ii
assay
fourth
day
cultiv
measur
amount
viru
antigen
use
immunoenzym
method
addit
fraction
vital
cell
determin
use
trypan
blue
exclu
sion
dosedepend
curv
construct
quantit
inhibit
characterist
determin
ic
compound
concentr
suppress
viru
product
protect
cell
death
due
infect
ic
compound
concentr
suppress
viru
product
protect
cell
death
due
infect
si
select
therapeut
index
ie
ratio
cc
effect
concentr
ic
tabl
present
result
effect
ii
rnadepend
dnapolymeras
activ
rt
use
recombin
rt
isol
express
vector
cultur
e
coli
accord
literatur
enzym
contain
six
histidin
nterminu
purifi
use
ninta
agaros
qiagen
hilden
germani
concentr
purifi
rt
determin
spectrophotometri
nm
use
molar
extinct
coeffici
cm
heterodimer
rt
rt
activ
determin
use
h
ttp
perkinelm
life
scienc
boston
usa
poli
riboa
oligo
dt
matrixprim
ge
healthcar
piscataway
nj
usa
rnadepend
dnapolymeras
activ
rt
determin
without
differ
concentr
ii
use
unitsml
poli
riboa
oligo
dt
rt
nm
h
ttp
mm
final
volum
ml
buffer
contain
trishcl
mm
ph
kcl
mm
mgcl
mm
sampl
incub
min
reaction
stop
ad
cold
trichloroacet
acid
tca
ml
contain
sodium
pyrophosph
mm
incub
min
ice
bath
sampl
filter
filter
contain
type
c
fiberglass
plate
millipor
bedford
usa
filter
rins
success
tca
etoh
amount
h
ttp
incorpor
precipit
nucleic
acid
count
use
liquidscintil
counter
